To investigate the effect of co existance of diabetes mellitus and chronic kidney disease on basic coagulation profile in comparison with diabetic patients with normal kidney function and non diabetic patients with chronic kidney disease
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Estimate risk of thrombosis or bleeding for the 3 study groups by prothrombin time
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by prothrombin concentration
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by INR
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by partial thromboplastin time
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by serum fibrinogen
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by mean platelet volume
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by platelet distribution width
Timeframe: 1 day
Estimate risk of thrombosis or bleeding for the 3 study groups by plateletcrit
Timeframe: 1 day